Nearly half of U.S. employers are shifting from merit-based raises to flat, across-the-board pay increases—a move that could provide crucial relief for lower-wage workers amid economic uncertainty.
Parker-Hannifin posts record-breaking Q2 fiscal 2026 results, fueled by robust organic growth and margin expansion, particularly in aerospace. The industrial giant raises full-year guidance and details strategic progress on its planned acquisition of Filtration Group Corporation.
Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.
Energy Transfer LP announced a significant increase to its quarterly distribution alongside a multi-billion dollar capital expenditure plan for new pipeline and infrastructure projects, signaling confidence in its cash flow stability and long-term growth prospects.
The U.S. dollar's recent plunge to multi-year lows has unsettled markets, fueling debate over the currency's future and the economic policies driving its decline.
Bridgestone Corporation's shares have delivered a robust 33% total return to shareholders over the past year, outpacing its recent short-term volatility. This performance prompts a closer look at whether the tire giant's current valuation still offers room for growth or if the market has already priced in its future prospects.
Shares of the boutique investment bank Perella Weinberg Partners have rallied sharply over the past month, riding a wave of renewed optimism in the advisory sector. However, its premium valuation and mixed long-term performance are prompting investors to weigh the risks against the potential rewards.
Woodward, Inc. (WWD) kicked off fiscal 2026 with robust first-quarter results, driven by exceptional performance in commercial aerospace services and broad-based industrial growth. The company reported a 29% year-over-year sales increase and a 54% jump in EPS, prompting an upward revision to its annual guidance.
Shares of Huntington Bancshares (HBAN) have climbed over 17% in the past 90 days, closing recently at $17.88. This rally has investors scrutinizing whether the regional bank's stock still holds value after its strong run, with some models suggesting a significant upside to fair value.
Shares of New York-focused REIT Alexander's have delivered impressive returns, but a closer look reveals a widening gap between its market price and key valuation metrics, prompting debate among investors.
Shares of First Mid Bancshares (FMBH) have surged approximately 17% over the past three months, prompting investors to scrutinize whether the regional lender's current valuation still offers value amidst its strong fundamentals and a potentially shifting interest rate landscape.
Bernstein analyst lifts ASML's price target to $1,911, citing a buying opportunity after recent pullback. The chip equipment giant's record Q4 orders and updated guidance signal confidence in the AI-driven semiconductor upcycle.
IAMGOLD (TSX:IMG) has reignited drilling at its Anik joint venture in Québec and issued updated production guidance, signaling accelerating operational momentum. The moves come as the gold miner's shares, despite recent volatility, have delivered staggering multi-year returns, highlighting a potential valuation gap.
Polish military police are investigating after a small, commercially available drone of unknown origin crashed inside a sensitive army facility in Przasnysz, highlighting persistent vulnerabilities in European airspace security.
Werner Enterprises' shares have rebounded strongly in recent weeks, but a deep dive into key valuation metrics suggests investors may be overlooking significant risks. Analysis indicates the stock appears substantially overvalued compared to both industry peers and its own projected cash flows.
Wells Fargo boosts its price target for Taysha Gene Therapies (TSHA), citing strong progress in its pivotal Rett syndrome gene therapy program. The company has dosed the first patient in a key trial phase and received FDA alignment on its regulatory pathway.
NETSTREIT Corp. (NYSE: NTST) has delivered impressive shareholder returns over the past year, significantly outpacing its longer-term performance. As the stock hovers near $19, investors and analysts are debating whether its current price fully reflects the fundamentals of this necessity-based retail REIT or if momentum has gotten ahead of value.
Goldman Sachs Group (GS) has approved a significant dividend increase and projects a robust earnings outlook for Corporate America, fueling debate over whether its strong share price momentum has outpaced its fundamental valuation.
CME Group has increased margin requirements for precious metals futures and options following extreme price swings, as daily trading volumes hit record highs. The exchange is also introducing new silver products and enforcing compliance measures, highlighting its dual role as a market facilitator and risk manager during turbulent times.
UBS analyst Peter Grom increased his price target for Kimberly-Clark (KMB) to $110, citing steady core performance despite lingering Kenvue-related uncertainties, after the consumer goods giant reported better-than-expected quarterly profit driven by cost discipline and resilient demand.
